Kennametal Announces Fiscal 2026 Second Quarter Results
Prnewswire· 2026-02-04 11:30
Core Insights - Kennametal Inc. reported strong second quarter results for fiscal 2026, with sales and adjusted EPS exceeding expectations, driven by volume increases and a favorable tungsten pricing environment [1][2] Financial Highlights - Sales reached $530 million, a 10% increase from $482 million in the same quarter last year, with organic sales growth of 10% and a favorable currency exchange effect of 1%, partially offset by a divestiture effect of 1% [2][7] - Operating income was $53 million, representing a margin of 9.9%, compared to $32 million and a margin of 6.6% in the prior year quarter, driven by favorable pricing and higher sales volumes [3][7] - Adjusted operating income was $56 million, or 10.5% margin, up from $33 million and 6.9% margin in the prior year [3][7] - Earnings per diluted share (EPS) were $0.44, up 92% from $0.23, while adjusted EPS was $0.47, an increase of 89% from $0.25 [7] Cash Flow and Capital Expenditures - Year-to-date net cash flow from operating activities was $73 million, down from $101 million in the prior year, primarily due to working capital changes [4] - Year-to-date free operating cash flow (FOCF) was $38 million, compared to $57 million in the prior year, also driven by working capital changes [4][27] Segment Performance - Metal Cutting sales were $331 million, an 11% increase from $298 million, with operating income of $30 million and a margin of 9.0%, up from 5.6% [9][20] - Infrastructure sales were $198 million, an 8% increase from $184 million, with operating income of $23 million and a margin of 11.8%, up from 8.5% [10][20] Outlook - The company expects third quarter sales to be between $545 million and $565 million, with adjusted EPS projected to be between $0.50 and $0.60 [8] - For the full fiscal year, sales are expected to be between $2.190 billion and $2.250 billion, with adjusted EPS projected to be between $2.05 and $2.45 [8] Dividend Declaration - The Board of Directors declared a quarterly cash dividend of $0.20 per share, payable on February 24, 2026, to shareholders of record as of February 10, 2026 [11]
Red Canyon Provides Drilling Update and Expands 2026 Targeting Plans at its 100% owned Kendal Copper Project
Thenewswire· 2026-02-04 11:30
Core Insights - Red Canyon Resources Ltd. has provided an exploration update for its 100% owned Kendal copper-molybdenum-gold-silver project, highlighting the completion of the 2025 targeted drill program and plans for 2026 [1][2][4] Company Highlights - The 2025 drill program at Kendal Ridge successfully intersected copper, molybdenum, gold, and silver mineralized porphyry veins, reinforcing confidence in the Kendal system's strength and scale [2][5] - The drilling results indicate that the company remains close to a higher-grade center of the mineralization system, with significant potential for further exploration [3][5] Drilling and Geological Insights - The Kendal project consists of five 100%-owned mineral claims totaling 2,738 hectares, located near Terrace, British Columbia, with excellent infrastructure [4][5] - The 2025 drill program included five holes totaling 2,548 meters, all of which intersected significant porphyry-style alteration and mineralization [5][6] - Assay results confirmed highly anomalous copper and molybdenum grades, with notable results from drill holes RCKD-25-007 and RCKD-25-010, indicating increasing mineralization with depth [10][25] Geochemical and Geophysical Programs - A large-scale soil geochemistry program was completed in the second half of 2025, identifying several new high-priority targets based on copper, molybdenum, gold, and silver anomalies [29][30] - The distribution of soil anomalies corresponds with significant geophysical features, emphasizing the scale of the potential mineralizing system [29][36] Future Exploration Plans - Plans for 2026 include targeting geochemical and geophysical anomalies identified east of Moly Fork and Kendal Creek, with infill geochemistry, IP geophysics, and diamond drilling anticipated to commence in Q2 2026 [43][44]
Cognizant Reports Fourth Quarter and Full-Year 2025 Results
Prnewswire· 2026-02-04 11:30
across key sectors including Financial Services, Healthcare and Life Sciences, Retail, and Manufacturing. The partnership will embed agentic AI and Copilot powered by Work IQ, Foundry IQ and Fabric IQ capabilities into mission-critical workflows. This partnership also expands on the Cognizant Neuro® AI Suite of offerings Cognizant is bringing to the market which leverage Microsoft cloud and AI services.- Adopted Anthropic's Claude, one of the world's most powerful family of large language models (LLMs), to ...
Lear Reports Fourth Quarter and Full Year 2025 Results
Prnewswire· 2026-02-04 11:30
SOUTHFIELD, Mich., Feb. 4, 2026 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, today reported results for the fourth quarter and full year 2025 and provided its financial outlook for the full year 2026. Fourth Quarter 2025 Highlights Delivered revenue of $6.0 billion in the fourth quarter, an increase of 5%, compared to $5.7 billion in the fourth quarter of 2024 Net income of $83 million and adjusted net income of $179 million, compared to $88 m ...
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Businesswire· 2026-02-04 11:30
A live webcast of the presentation will be available in the Investors section of the Company's website under News & Events. A replay will remain archived for at least 30 days. ABOUT ZURA HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ("Zura†or the Zura's lead product candidate, tibulizumab (ZB-106), is being evaluated in two Phase 2 clinical studies in adults: TibuSHIELD, a study in hidradenitis suppurativa (HS), and TibuSURE, a study in systemic sclerosis (SSc). Additional product candid ...
CGI expands presence in Atlanta with Stratfield Consulting
Prnewswire· 2026-02-04 11:30
Stock Market Symbols GIB.A (TSX) GIB (NYSE) cgi.com/newsroom ATLANTA, Feb. 4, 2026 /PRNewswire/ - CGI (TSX: GIB.A) (NYSE: GIB), one of the world's largest independent technology and professional services firms, today announced the signing of an agreement to acquire Stratfield Consulting, further strengthening CGI's position in Atlanta, a key U.S. growth market. The combination is expected to be completed in February 2026, subject to customary closing conditions. An Atlanta-based management and technology co ...
Cencora Reports Fiscal 2026 First Quarter Results
Businesswire· 2026-02-04 11:30
Form 10-K for the fiscal year ended September 30, 2025 and elsewhere in that report and (ii) in other reports filed by the Company pursuant to the Securities Exchange Act. The Company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by the federal securities laws.CENCORA, INC.FINANCIAL SUMMARY(in thousands, except per share data)(unaudited)Three MonthsEndedDecember 31, 2025% ofRevenueThree MonthsEndedDecember 31, 2024% ofRevenue%ChangeRevenue$85,932,01 ...
Equifax Delivers Fourth Quarter 2025 Revenue Growth of 9% Despite Weaker U.S. Hiring and Mortgage Markets
Prnewswire· 2026-02-04 11:30
ATLANTA, Feb. 4, 2026 /PRNewswire/ -- Equifax (NYSE: EFX) today announced financial results for the quarter and full year ended December 31, 2025. "Equifax delivered strong fourth quarter revenue of $1.551 billion, up 9% on both a reported and local currency basis, that was $30 million above the midpoint of our October guidance. This was led by strong 20% U.S. Mortgage revenue growth, strong Workforce Solutions Government revenue growth, and continued momentum in New Product Innovation with a Vitality Index ...
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
Prnewswire· 2026-02-04 11:30
BURLINGTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's announcement in the first fiscal quarter of 2025 of its intention to pursue a sale and the entry into a definitive agreement to sell the business, which is expected to close on or before March 31, 2026. Quarter Ended | Dolla ...
Boston Scientific announces results for fourth quarter and full year 2025
Prnewswire· 2026-02-04 11:30
123 MARLBOROUGH, Mass., Feb. 4, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.286 billion during the fourth quarter of 2025, growing 15.9 percent on a reported basis, 14.3 percent on an operational basis and 12.7 percent on an organic basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $672 million or $0.45 per share (EPS), compared to $566 million or $0.38 per share a year ago, ...